Thursday May 3rd
|Meeting room Telemark|
|Sponsored session Novartis/Sandoz
Rejection in organ transplanted patients: what role does adherence play? Monitoring of immunosuppressive drugs, gold standards and novel approaches
Chair: Professor Anders Åsberg, Oslo University Hospital, Rikshospitalet, Norway
Current challenges in therapeutic drug monitoring in Scandinavia
A practical solution for TDM using home micro-sampling
James Rudge, Neoteryx LLC, USA
Forming a patient-doctor alliance through home TDM
Jon Jin Kim, Nottingham Children’s Hospital, UK
Discussion & Questions from the audience
Anders Åsberg & Speaker Panel
|09:15-10:30||Poster + Exhibition with coffee break|
|10:30-11:00||Diagnosis of death in DCD - the UK experience
Paul Murphy, Leeds UK
|11:00-11:15||cDCD in the Nordic countries: Current status
Markus Gäbel, Gothenburg Sweden and
Dag Wendelboe Sørensen, Oslo Norway
|11:15-11:45||cDCD: Ethical considerations (panel discussion)
Corinne Antoine, Paris France,
Morten Horn, Oslo Norway and Paul Murphy, Leeds, UK and Geir Bjørsvik, Norway
|11:45-12:00||Coffee break + Exhibition with coffee break|
|12:00-13:00||Sponsored session: Chiesi (lunch):
Different patients, different needs; can we do more?
Chairs: Lars Wennberg - Karolinska University, Hospital, Sweden.
Patients with “recognised” sensitivity to tacrolimus pharmacokinetics: Risk factors and implications for treatment.
Lucrezia Furian – Padua University Hospital, Italy.
Patients with “hidden” sensitivity to tacrolimus pharmacokinetics:
Identification and management.
Klemens Budde – Charité University Hospital, Berlin, Germany
|13:00-18:00||Parallel Session A and B|
|19:00-22:00||Conference Dinner at Sjømagasinet, Tjuvholmen|